Incyte Corp (NASDAQ:INCY)

100.54
Delayed Data
As of May 06
 +3.04 / +3.12%
Today’s Change
43.86
Today|||52-Week Range
111.93
+37.52%
Year-to-Date

Today’s Trading

Previous close97.50
Today’s open98.81
Day’s range-- - --
Volume1,322,698
Average volume (3 months)1,218,450
Market cap$17.5B
Dividend yield--
Data as of 05/06/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+15.67%
Earnings growth (next 5 years)+219.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+5.78+5.07%
PCYCPharmacyclics Inc+1.48+0.58%
HSPHospira Inc-0.02-0.02%
ENDPEndo International P...-0.03-0.04%
Data as of 05/06/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers